No abstract available
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Agents / therapeutic use
-
Antineoplastic Agents, Alkylating / administration & dosage
-
Antineoplastic Agents, Alkylating / adverse effects
-
Antineoplastic Agents, Alkylating / therapeutic use*
-
Boronic Acids / therapeutic use
-
Bortezomib
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / adverse effects
-
Cyclophosphamide / therapeutic use*
-
Drug Resistance, Neoplasm*
-
Hospitals, University
-
Humans
-
Immunologic Factors / therapeutic use
-
Leukemia, Plasma Cell / drug therapy*
-
Middle Aged
-
Multiple Myeloma / drug therapy*
-
Protease Inhibitors / therapeutic use
-
Pyrazines / therapeutic use
-
Retrospective Studies
-
Salvage Therapy* / adverse effects
-
Severity of Illness Index
-
Survival Analysis
Substances
-
Antineoplastic Agents
-
Antineoplastic Agents, Alkylating
-
Boronic Acids
-
Immunologic Factors
-
Protease Inhibitors
-
Pyrazines
-
Bortezomib
-
Cyclophosphamide